subject: Aarkstore Enterprise -drug Discovery In India And China -- Market Research Aggregation [print this page] Aarkstore announce a new report " Aarkstore Enterprise -Drug Discovery in India and China -- Market Research Aggregation" through its vast collection of market research report.
Summary
The leading business intelligence provider, has released its latest report, Drug Discovery in India and China - Gaining Momentum with Increasing Pressure on Cost Cutting. It provides key data, information and analysis of the major trends and issues affecting the drug discovery market in India and China. The report provides a comprehensive insight into the drug discovery process and the model followed by the companies providing such services. The report also provides a detailed analysis of the factors that are driving the drug discovery market, a key segment of the pharmaceutical and healthcare industry, in India and China. The report talks about the key regulations, especially with respect to intellectual property rights protection, and how these regulations have benefited drug discovery companies in these two nations. The study analyses key partnerships between the local companies in the two countries and their western counterparts and the key trends emerging out of such partnerships. It also provides an insight into the government support initiatives in these countries to encourage the drug discovery research. This research provides a comparative analysis of the two countries and the major differences between India and China when it comes to drug discovery.
This report is built using data and information sourced from proprietary databases, primary and secondary research and in house analysis by GBI Researchs team of industry experts.
Scope
The scope of this report includes:
- Study of major discovery research services including medicinal chemistry, Drug Metabolism and Pharmacokinetics (DMPK), pharmacology and toxicology offered by the Indian and the Chinese drug discovery companies
- Analysis of major therapeutic areas under drug discovery research such as oncology, inflammatory diseases and metabolic diseases
- Study of key Indian and Chinese drug discovery players such as Aurigene, Syngene, WuXi and Shanghai ChemPartner, and their deals/partnerships with western pharma companies
- Analysis of key intellectual property regulations and government support in India and China affecting the drug discovery market
- Analysis of the key drivers that are fueling the growth of the drug discovery market in India and China and future outlook of the drug discovery market in India and China
